Skip to main content
. Author manuscript; available in PMC: 2017 Aug 7.
Published in final edited form as: Curr Hypertens Rep. 2016 Jun;18(6):46. doi: 10.1007/s11906-016-0656-3

Table 1.

Main work definitions for the metabolic syndrome

Definition AHA/NHLBI 2009[4] NCEP-ATPIII 2004[2] IDF 2005[3]
Mandatory criteria
None None WCa with ethnicity specific values
For Europeans:
≥ 94 cm (men)
≥ 80 cm (women)
Additional criteria At least 3 of the following features At least 3 of the following features At least 2 of the following features
Central Obesity Increased WCa,b WC ≥ 102 cm (men)
WC ≥ 88 cm (women)
Triglycerides (TG) ≥ 150 mg/dL (1.7 mmol/L)
or specific drug treatment for elevated TG
≥ 150 mg/dL (1.7 mmol/L)
or specific drug treatment for elevated TG
≥ 150 mg/dL (1.7 mmol/L)
or specific drug treatment for elevated TG
HDL-cholesterol < 40 mg/dL (1.0 mmol/L) (men)
< 50 mg/dL (1.3 mmol/L)(women)
or specific drug treatment for dyslipidaemia
< 40 mg/dL (1.0 mmol/L) (men)
< 50 mg/dL (1.3 mmol/L)(women)
or specific drug treatment for dyslipidaemia
< 40 mg/dL (1.0 mmol/L) (men)
< 50 mg/dL (1.3 mmol/L)(women)
or specific drug treatment for dyslipidaemia
Blood Pressure SBP ≥ 130 or DBP ≥ 85 mmHG or specific treatment for hypertension SBP ≥ 130 or DBP ≥ 85 mmHG or specific treatment for hypertension SBP ≥ 130 or DBP ≥ 85 mmHG or specific treatment for hypertension
Fasting glucose ≥ 100 mg/dL (5.5 mmol/L)
or specific treatment for hyperglycaemia
≥ 100 mg/dL (5.5 mmol/L)
or specific treatment for hyperglycaemia
≥ 100 mg/dL (5.5 mmol/L)
or previously diagnosed type 2 diabetes
a

Waist circumference

b

It is recommended that the IDF cutoffs are used for non-Europeans and either the IDF or NCEP-ATPIII cut points used for people of European origin until more data are available.